InvestorsHub Logo
Followers 44
Posts 7732
Boards Moderated 0
Alias Born 07/09/2010

Re: koronis post# 119905

Wednesday, 09/14/2016 1:59:52 PM

Wednesday, September 14, 2016 1:59:52 PM

Post# of 129051
This is what you said Dabney ...please update shareholders...did you fail again....or were you just padding your wallet with false and misleading news...l...really address this ..lie or failure again !!!
CANNABIS SCIENCE ORDERS FIRST BATCH INHALATION MEDICATION AND ADDS CBIS MDI RESCUE INHALER FOR ASTHMA/COPD VIA NEBULIZER, TARGETING 25+ LEGAL STATES, AND NATIONAL MARKET VARIABLES

IRVINE, CA--(Marketwired - Aug 11, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed. It is expected to be received by the company within a week and released initially in select California dispensaries and available for delivery. The CBIS MDI Rescue Inhaler dosage is targeting 100 - 200 dose MDI with cannabinoid level variations ranging from 10mg, 25mg, up to 100mg THC, CBD, and other cannabinoid variables as patient/consumer analysis moves further down the road.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.